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ABSTRACT
Human herpesvirus-6A (HHV-6A) and HHV-6B inte-
grate their genomes into the telomeres of human
chromosomes, however, the mechanisms leading to
integration remain unknown. HHV-6A/B encode a
protein that has been proposed to be involved in inte-
gration termed U94, an ortholog of adeno-associated
virus type 2 (AAV-2) Rep68 integrase. In this re-
port, we addressed whether purified recombinant
maltose-binding protein (MBP)-U94 fusion proteins
of HHV-6A/B possess biological functions compati-
ble with viral integration. We could demonstrate that
MBP-U94 efficiently binds both dsDNA and ssDNA
containing telomeric repeats using gel shift assay
and surface plasmon resonance. MBP-U94 is also
able to hydrolyze adenosine triphosphate (ATP) to
ADP, providing the energy for further catalytic ac-
tivities. In addition, U94 displays a 3′ to 5′ exonu-
clease activity on dsDNA with a preference for 3′-
recessed ends. Once the DNA strand reaches 8–10
nt in length, the enzyme dissociates it from the com-
plementary strand. Lastly, MBP-U94 compromises
the integrity of a synthetic telomeric D-loop through
exonuclease attack at the 3′ end of the invading
strand. The preferential DNA binding of MBP-U94 to
telomeric sequences, its ability to hydrolyze ATP and
its exonuclease/helicase activities suggest that U94
possesses all functions required for HHV-6A/B chro-
mosomal integration.
INTRODUCTION
The human beta-herpesvirus subfamily is composed of
four viruses: human cytomegalovirus (CMV), human her-
pesvirus (HHV)-6A (HHV-6A), HHV-6B and HHV-7.
Based on epidemiological, biological andmolecular charac-
teristics, HHV-6A andHHV-6Bwere recently recognized as
distinct viruses rather than viral variants (1,2). HHV-6B is
the etiological agent of the sixth disease (roseola infantum)
(3) and with virus reactivation being associated with vari-
ous problems including encephalitis in hematopoietic stem
cell transplantation, especially when using cord blood as the
source of stem cells (4). The epidemiology and disease asso-
ciations with HHV-6A are less clear.
Intriguingly, HHV-6A and HHV-6B have been shown to
integrate their genomes into the telomeres of human chro-
mosomes, while most herpesviruses maintain their genomes
as extra chromosomal circular episomes in the nucleus of
infected cells during latency. HHV-6 chromosomal integra-
tion was first discovered in the mid 1990’s, when Luppi
and colleagues identified the presence of integrated HHV-
6 DNA into the chromosomes of freshly isolated peripheral
blood mononuclear cells (PBMC) (5–7). Several indepen-
dent investigators have confirmed these findings (reviewed
in (8,9)). This integration can occur in both somatic and
germ cells. Chromosomal integration into germ cells can
result in individuals that harbor HHV-6A/B in every sin-
gle cell of their body. Fifty percent of their descendants
will inherit this condition, which we referred to as inher-
ited chromosomally-integrated HHV-6 (iciHHV-6). It is es-
timated that between 0.5–1% of the world population are
iciHHV-6+ and carry an integrated copy of the HHV-6A/B
genome in every cell of their body (8–10). Both HHV-6
species can integrate, with HHV-6B integration represent-
ing two-thirds of iciHHV-6 cases reported so far (8). Recent
reviews address some of the biological issues and concerns
associated with iciHHV-6 (8,10–12). Work by Arbuckle et
al. indicates that integration also occurs in cell infected in
vitro, indicating that HHV-6A/B integration can be quite
common and not only occurs in the germ line (13). The
underlying mechanisms of HHV-6A/B integration remain
completely unknown.
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The HHV-6A/B genome consists of a single unique com-
ponent (U) (∼145 kbp) flanked by identical direct repeats
(DR) (∼9 kbp) (14–17) that are flanked by the cleavage and
packaging signals pac1 and pac2 (18,19). Adjacent to the
pac2 sequences are arrays of TTAGGG repeats that are
identical to the human telomeric repeat sequence (TRS).
In addition, imperfect TRS referred as het(TAACCC)n
are adjacent to pac1 (16,19). Intriguingly, TRS are found
in several lymphotropic herpesviruses belonging to the -
herpesvirinae (20–23), -herpesvirinae (14,16,24,25) and  -
herpesvirinae (26). While HHV-6A/B (5–7) and the onco-
genicMarek’s disease virus (MDV) (27,28) have been shown
to integrate into host chromosomes, it remains unclear if
the other TRS-containing virus including HHV-7, a close
relative of HHV-6A/B, are capable of integration (29). The
TRS in the MDV genome have been shown to facilitate
integration into host telomeres, a process that is essential
for efficient pathogenesis and tumor formation (30). It has
been hypothesized that homologous recombination events
between the viral TRS and host telomeres results in viral
integration (8,9). All integration sites identified so far local-
ize the HHV-6A/B genome in the telomeric/sub-telomeric
regions (1q44, 9q34.3, 10q26, 11p15.5, 17p13.3, 18p11.3,
18q23, 19q13.4 and 22q13.3) (reviewed in (8)). One factor
that is thought to play a role in HHV-6A/B integration is
the putative integrase U94, coding for 490 amino acid pro-
tein homologous (24% identity) to the AAV Rep78/68, a
non-structural protein essential for AAV integration within
chromosomes 19 (31–33). U94 is unique to HHV-6A and
HHV-6B with no ortholog in other human herpesviruses.
The U94 protein is identical between isolates of the same
species ((34) and Trempe and Flamand unpublished data)
and shares a 97% amino acid identity between HHV-6A
and HHV-6B species (15,17). The only other known her-
pesvirus having an open reading frame (ORF) (r127) ho-
mologous to AAV Rep78/68 is rat CMV (35). Rat CMV
does not harbor TRS and it remains unknown if this virus
integrates into host chromosomes. HHV-6B U94 mRNA
and protein are expressed at very low level during infec-
tion (34) and ectopic expression ofU94 inhibitsHHV-6 lytic
replication (36), angiogenesis and lymphomagenesis in can-
cer cells (37). U94 demonstrates single-strandedDNAbind-
ing properties (36,38,39) and is reported to interact with
TATA-binding protein (39). However, the molecular func-
tions of HHV-6A/B U94 remain largely unknown.
In this report, we determined the molecular functions
of U94 including those of Rep78/68 prove essential for
AAV parvoviral integration (40). We could demonstrate
that HHV-6A/B U94 possess DNA-binding, exonuclease
and helicase-ATPase activities that are compatible with in-
tegration of HHV-6 into host telomeres.
MATERIALS AND METHODS
Prokaryotic expression vectors
The U94 ORF was amplified by polymerase chain reaction
(PCR) using HHV-6A GS and HHV-6B Z29 viral DNA
as template. PCR reactions (50 l) contained the follow-
ing reagents: 1× reaction buffer, 10 ng of viral DNA, 0.4
M of each primer, 200 M dNTP and 2.5 units of poly-
merase Expand High FidelityPLUS PCR System (Roche Di-
agnostics, Laval, Canada). Products were amplified as fol-
low: 94◦C for 2 min, ten cycles of [30 s at 94◦C, 30 s at 50◦C
and 2 min at 72◦C], 20 cycles of [30 s at 94◦C, 30 s at 50◦C
and 2 min + 10 s per cycle at 72◦C] to finish with a 7 min
at 72◦C. The following primer pair was used: U94 forward
5′-CGCGGATCCTTTTCCATAATA AATCC-3′ and U94
reverse 5′-CGCAAGCTTTTATAAAATTTT(C/T)GG-3′
(Integrated DNA Technologies, Coralville, IA, USA). To
facilitate cloning, restriction sites (underlined) were in-
cluded at the 5′-end of each primer. PCR products were
run on a 0.8% agarose gel and extracted with the QIAquick
Gel extraction kit (Qiagen, Toronto, Canada). The purified
PCR product was digested with BamHI (New England Bi-
olabs Inc., Whitby, Canada) and HindIII (Roche Diagnos-
tics) and ligated into BamHI/HindIII digested pMAL-c2
vector (NEB). Sequencing confirmed that U94 was ligated
in-frame with maltose-binding protein (MBP). The pMAL-
c2-Rep68 plasmid was obtained from R.A. Owens (Na-
tional Institute of Diabetes and Digestive and Kidney Dis-
eases, National Institutes of Health, Bethesda, MD, USA)
(41).
Production and purification of recombinant proteins
BL21-RIL Escherichia coli bacteria (Agilent Technologies
Canada Inc., Mississauga, Canada) were transformed with
100 ng of pMAL-c2 or fusion construct (MBP-U94A,
MBP-U94B, MBP-Rep68). Bacteria were plated on LB
agar with 100 g/ml of ampicillin and 25 g/ml of chlo-
ramphenicol and grown at 37◦C overnight. The next day,
bacterial pre-cultures were used to inoculate (1:100 dilu-
tion) two 2-l flasks containing 500 ml of LB and antibiotics.
Bacteria were grown at 37◦C with agitation (250 rpm) for
∼3 h until the optical density at 600 nm (D.O.600 nm) reached
0.4–0.6. Protein expression was induced by adding 0.3 mM
of isopropyl -D-1-thiogalactopyranoside (IPTG) (Fisher
Scientific, Ottawa, Canada) to each flask. The cultures were
switched to room temperature and incubated overnightwith
agitation. Bacterial cultures were centrifuged at 4000 × g
using a Sorvall RC 3C PLUS centrifuge (rotor H6000A) for
20 min at 4◦C. Bacteria were resuspended in a total of 20
ml of resuspension buffer (20 mM Tris–HCl pH 7.5, 1 mM
DTT, 1mMEDTA, 200mMNaCl) and lysed by sonication
(2.5 min at output 3.5) on ice using a Sonifier 450 (Branson,
Danbury, CT, USA). Samples were centrifuged at 9000 × g
in an Avanti J-E with JA-20 rotor (Beckman Coulter, Mis-
sissauga, Canada) for 30 min at 4◦C and supernatants were
diluted 1:10 with resuspension buffer. MBP recombinant
proteins were purified using MBPTrapTM HP 1 ml column
(GE Healthcare, Uppsala, Sweden) and A¨KTAprime plus
purification system (GE Healthcare). The purified proteins
were dialyzed two times against 1 l of phosphate buffered
saline (PBS) using Slide-A-Lyzer Dialysis cassettes with
10Kmolecular weight cut off (Thermo Scientific, Rockford,
IL, USA). Protein concentrations were determined using
the bicinchoninic acid assay (BCA) (Thermo Scientific). All
proteins were aliquoted and stored at −80◦C.
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Western blot and coomassie blue staining
Purified recombinant proteins were analyzed by western
blot and coomassie blue staining. MBP-U94A, MBP-
U94B, MBP-Rep68 and MBP proteins were loaded and
electrophoresed through 7.5% polyacrylamide-sodium do-
decyl sulphate (SDS) gels. Gels were stained using
coomassie blue solution (0.025% Coomassie Brillant Blue
R-250, 40% methyl alcohol, 10% glacial acetic acid and
50% water), destained and dried. For western blots, mi-
grated proteins were transferred on PVDF membranes
(Immobilon R© Millipore, Etobicoke, Canada). Membranes
were blockedwith a solution of 5%non-fatmilk in TBS con-
taining 0.01% Tween 20 (TBST). Membranes were probed
with a polyclonal rabbit anti-MBP diluted 1:1000 (Ap-
plied Biological Materials Inc., Richmond, Canada) for
one hour at room temperature. After three 5-min washes
with TBST, the secondary antibody, a peroxidase-labeled
goat anti-rabbit IgG antibody diluted 1:10000 (Jackson Im-
muno Research Laboratories, Inc., West grove, AR, USA)
was added for 1 h at room temperature. After three 5-
min washes with TBST, labeled proteins were visualized by
enhanced chemiluminescence (Western Lightning R© Plus-
ECL, PerkinElmer, Woodbridge, Canada).
Surface plasmon resonance assay (SPR)
All surface plasmon resonance assay (SPR) experiments
were conducted using the ProteOn XPR36 apparatus (Bio-
Rad, Mississauga, Canada). Biotin-labeled DNA oligonu-
cleotides were attached to the surface of a neutravidin-
coated NLC chip (Bio-Rad). The neutravidin-coated NLC
chip (Bio-Rad) was preconditioned by injecting a 1MNaCl
and 50 mMNaOH solution in the two directions (horizon-
tally and vertically). Biotinylated-oligonucleotides (Human
TRS G-rich, human TRS C-rich, HHV-6 TRS C-rich, ran-
dom sequence, HHV-6 TRS and ITR AAVS1 Rep bind-
ing site (AAV-2)) were diluted to 5 × 10−5 g/l in PBS
containing 0.05% Tween-20 (PBST). The equivalent of 60
Response Unit (RU) of biotinylated-oligonucleotides was
attached to the NLC chip. We next blocked free neutra-
vidin groups by injecting a PBST solution containing 1 nM
biotin. The chip was then ready for protein binding anal-
yses. Between each of these injections, a three-step regen-
eration (2 M NaCl, 5 mM NaOH + 0,5 M NaCl, 0,1%
SDS) program was performed to remove residual binding.
Binding buffer used to dilute injected proteins consisted of
20 mM NaHEPES pH 7.4, 0.1 M NaCl, 10 mM MgCl2,
0,1% Tween-20, 1 mg/ml BSA and 0.83 mM of adenosine
triphosphate (ATP). Proteins were injected at 50 l/min
over 180 s followed by a dissociation time of 600 s. For
most protein, six different concentrations were used: 800,
400, 200, 100, 50 and 0 nM.
Similar studies were also conducted using biotinylated
DNA oligonucleotides containing a single CCCTAA mo-
tif. Oligonucleotides were injected at the same concentra-
tion as described above, except that various proteins con-
centrations were used (1, 0.5, 0.25, 0.125 or 0.0625 M).
Electrophoretic mobility shift assay
Ten pmoles of oligonucleotides were 5′-end-labeled using 15
Ci ATP-[ 32P] (Perkin Elmer) and 20 units of T4 PNK
(USBOptikinaseTM, Affymetrix, Santa Clara, CA,USA) in
a 25 l reaction volume. After 30 min at 37◦C, the reaction
was stopped by incubation at 65◦C for 20 min. The reaction
volume was adjusted to 50 l with sodium chloride-Tris-
EDTA (STE) buffer and labeled oligonucleotides isolated
using a ProbeQuantTM G-50 column (GE Healthcare).
Oligonucleotides were annealed by mixing with equimolar
of complementary oligonucleotides in 1× SSC buffer and
heated at 100◦C for 5 min, followed by gradual cooling to
room temperature. In all electrophoreticmobility shift assay
assays, we used 1 g of MBP-Rep68, MBP-U94A or MBP-
U94B (all approximately 95 kDa) and 0.5 g for MBP (50
kDa) to have an equal amount of molecules per reaction.
For each reaction, 20 000 cpm of labeled probe were added
to proteins in a final volume of 20 l of 1× binding buffer
[30 mMHEPES-KOH pH 7.5, 7 mMMgCl2, 4 mMATP, 1
mMDTT, 0.1 mg/ml of BSA and 5% glycerol] and the reac-
tionwas incubated at 37◦C for 1 h. Tenmicroliters of 2×mi-
gration buffer [TAE 1×, 0.025% bromophenol blue, 0.025%
xylene cyanol and 6% glycerol] were added to each tube and
samples were loaded and electrophoresed through a non-
denaturing 6% acrylamide:bis (29:1) gel. The gels were dried
and exposed to X-ray films.
ATPase assays in vitro
Adenosine triphosphatase (ATPase) activity wasmonitored
by an in vitro assay. Reactions were carried out in a final
volume of 10 l where 0.5 g of purified proteins were in-
cluded in reaction buffer [50 mM Tris–HCl pH 8, 20 mM
NaCl and 2.5 mMMgCl2] with or without 0.2 g of DNA
(single or double stranded) and 1.25 × 10−10 moles of ATP.
Reactions were incubated at room temperature for 0 or 60
min and stopped by transferring tubes on ice. Samples were
first treated with 20 l of 8 M HClO4 for 3 min on ice.
Then, the reaction was equilibrated to neutral pH by adding
60 l of 4 M K2HPO4. Fifty ng (5 l) of internal stan-
dard (2 Cl-AMP) were added to each tube. Finally, samples
were centrifuged at 12 000 × g for 5 min at 4◦C, the super-
natants were collected and stored at −80◦C until analyzed
by high performance liquid chromatography (HPLC). The
HPLC purification procedure represents a modified version
of a previous published report (42). The column (Synergi 4
 hydro-RP80A◦ 150 × 4.6 mm (Phenomenex, Terrance,
CA, USA)) was refrigerated at 12◦C and equilibrated in
200 mM sodium phosphate buffer pH 5.8 (solvent A). The
solvent flow rate was adjusted to 1 ml/min. To determine
the retention time of the various products, a standard cal-
ibrated solution containing the following products (ATP,
adenosine diphosphate (ADP), adenosine monophosphate
(AMP), hypoxanthine, 2 Cl-AMP) was injected before and
after each experiment. The elution profiles were determined
by measuring the absorbance at 260 nm. A total of 75 l
of each sample were injected into the system. Samples were
eluted using (solvent B), a 0–25% methanol and 200–150
mM sodium phosphate buffer pH 5.8 linear gradient over a
7 min time lapse. After a second 7-min incubation in buffer
B, the column was re-equilibrate in solvent A for 12 min.
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Assembly of synthetic telomeric D-loop
A synthetic telomeric D-loop was generated by the succes-
sive assembly of three oligonucleotides (BB, BT and INV)
(Supplementary Table 1) as described (43). BB and BT con-
tain three phosphorotioate bonds (PS) at the 3′ extremities
to prevent exonuclease attack from these sites. The integrity
of the structure was analyzed by gel electrophoresis and by
digestion with FokI and HpaI restriction endonucleases.
Helicase assay
Ten pmoles of probeswere 5′-end labeled using 15CiATP-
[ 32P] (Perkin Elmer) and 20 units of T4 PNK in a 25 l
reaction volume. After 30 min at 37◦C, the reaction was
stopped by incubation at 65◦C for 20 min. The reaction
volume was adjusted to 50 l with STE buffer and labeled
probes isolated using a ProbeQuantTM G-50 column (GE
Healthcare). Probes were annealed to various unlabeled
oligonucleotides in a 1:20 ratio in 1× SSC buffer by heat-
ing at 100◦C for 5 min followed by gradual cooling to room
temperature. The amount of radioactive probe was deter-
mined using a scintillation counter (Perkin Elmer). The he-
licase assay was carried out in a 10 l volume containing
20 000 cpm of labeled probe, 1–3 g of the protein of inter-
est (MBP, MBP-U94A, MBP-U94B), +/−10 mM ATP, 25
mM Tris–HCl pH 7.4, 5 mMMgCl2, 5 mMDTT, and 1 g
of BSA. The helicase reaction was allowed to proceed for 1
h at 37◦C and stopped by adding 10 l of 2× loading buffer
(TAE 1X, 0.025% bromophenol blue, 0.025% xylene cyanol
and 6% glycerol). Samples were loaded and electrophoresed
through a non-denaturing 6% acrylamide:bis (29:1) gel. The
gels were dried and exposed to X-ray films.
Exonuclease assay
Oligonucleotides were 5′-end labeled using T4 PNK and
annealed as described above. In some instances, the phos-
phodiester bonds of the two last nucleotides were substi-
tuted with phosphorotioate bonds. The exonuclease assay
was carried out in a 10 l volume containing 20 000 cpm
of labeled probe, 1–3 g of the protein of interest (MBP,
MBP-U94A,MBP-U94B), 25 mMHEPES-KOH pH 7.5, 5
mMMgCl2, 20 mMNaCl, 1 mMDTT and 0.1 g of BSA.
The reaction was allowed to proceed for various time (1–
120 min) at 37◦C and stopped by adding 10 l of 2× load-
ing buffer (TAE 1×, 50% formamide, 0.025% bromophenol
blue, 0.025% xylene cyanol and 6% glycerol). Samples were
loaded onto and electrophoresed through a 16% denaturing
acrylamide:bis (29:1) gel. The gels were dried and exposed
to X-ray films.
RESULTS
Sequence alignment of HHV-6A/B U94 and AAV-2 Rep68
proteins
The U94 proteins of HHV-6A (U94A) and HHV-6B
(U94B) are among the most conserved proteins between the
two viral species with 97.5% amino acid identity (15,17).
HHV-6 U94 can functionally complement an AAV-2 Rep68
deletion mutant, suggesting that U94 possesses some of the
biological activities of Rep78/68 (40). The Rep68 domains
essential for the various enzymatic activities were previously
characterized (44–46). To determine if these domains are
conserved in the U94 protein of HHV-6A/B, we performed
sequences alignments with Rep68 (Figure S1). The overall
amino acid identity between Rep68 and U94A and U94B is
24%. Several of the amino acids required for the enzymatic
activities of Rep68 (red boxes) are conserved within U94A
and U94B.
DNA-binding properties of HHV-6A and HHV-6B U94 pro-
teins
Previous work indicated that HHV-6 U94 binds single-
stranded DNA (ssDNA) but has a low affinity for double-
stranded DNA (dsDNA) (38). To determine if U94 binds
ssDNA in a sequence specific manner allowing integration
of HHV-6A/B into host telomeres, we determined whether
U94 binds to ssDNA sequences containing the TRS mo-
tifs. First, we generated MBP-U94A and MBP-U94B ex-
pression vectors, expressed the proteins in E. coli and puri-
fied them by affinity chromatography (Supplementary Fig-
ure S2). Purified MBP and MBP-Rep68 were also pro-
duced and used as controls. To determine if MBP-U94
indeed binds TRS ssDNA, we performed gel shift assays
using end-labeled ssDNA oligonucleotides containing the
(TTAGGG)7 motifs (Supplementary Table 1). MBP-U94A
and MBP-U94B efficiently bound to the TTAGGG motifs
(Figure 1), while the MBP control protein showed minimal
binding to the labeled probe. Addition of a 100-fold excess
of unlabeled oligonucleotide with homologous (identical)
or random sequences abrogated binding. Lysine 391 was
previously shown to play an important role in the Rep68
DNA-binding activity (44). We mutated the corresponding
lysine of U94 to alanine (K395A) and could demonstrate
that theMBP-U94A andMBP-U94BK395Amutants were
severely impaired in the binding to the (TTAGGG)7 ssDNA
compared toMBP-U94A orMBP-U94B. Residual binding
was eliminated by both homologous (identical) and random
DNAs.
Previous studies showed that HHV-6A/B U94 does not
bind to unspecific dsDNA (36,38); however, it remained
unclear if it has an affinity to dsDNA containing telom-
eric motifs. To address this question, we performed mo-
bility shift assays and could demonstrate that both MBP-
U94A and MBP-U94B interact with end-labeled TRS ds-
DNA (Figure 2), with MBP-U94B binding more efficiently
than MBP-U94A. No binding was observed with the MBP
control protein. As shown above, binding could be abro-
gated using an excess of unlabeled homologous and random
dsDNAs. In addition, mutation of K395 also affected bind-
ing of MBP-U94A/B proteins, albeit this was more pro-
nounced for MBP-U94B. Our data demonstrates that the
MBP-U94 proteins from HHV-6A/B are able to bind ss-
DNA and dsDNA containing telomeric motifs. This bind-
ing could be eliminated by random DNAs, suggesting that
MBP-U94 can also bind ssDNA and dsDNA in a sequence
independent manner.
To determine the MBP-U94 affinity toward TRS rela-
tive to unspecific DNA sequences, we performed SPR to
determine the association and dissociation of MBP-U94
 at Freie U







6088 Nucleic Acids Research, 2015, Vol. 43, No. 12
Figure 1. HHV-6 U94 binds single-stranded TTAGGG probes. Proteins
(MBP, MBP-Rep68, MBP-U94A, MBP-U94B and MBP-U94 K395A)
were incubated with 32P 5-end labeled (TTAGGG)7 probe for 30 min at
37◦C in the absence or in the presence of identical (homologous) or ran-
dom competitor DNA. Loading dye was added to the samples and these
were electrophoresed through a non-denaturing gel. After migration the
gel was dried and exposed to imaging plates. Results are representative of
two independent experiments.
to the ssDNA and dsDNA in real time (oligo sequences
are presented under Supplementary Table 1). MBP and
MPB-Rep68 were used as negative and positive controls,
respectively (Figure 3A). No binding was observed for the
MBP protein, while MBP-Rep68 showed a strong interac-
tion with its natural ligand AAV S1 dsDNA as described
previously (47). We could demonstrate that MBP-U94B ef-
ficiently binds (TTAGGG)7 and (CCCTAA)7 ssDNA (Fig-
ure 3B) with a 100× greater affinity for the CCCTAA mo-
tif with a KD of 13.7 nM. To confirm that MBP-U94
also binds to the TRS sequences in the HHV-6 genome,
we performed SPR using HHV-6 derived CCCTAA mo-
tifs (HHV6A/B C-rich TRS) and dsDNA (Figure 3B). We
could demonstrate that MBP-U94B efficiently binds HHV-
6A/B dsDNA carrying telomeric repeats. DNA binding
was sequence specific as MBP-U94B did not bind a scram-
bled ssDNA sequence of similar length (Figure 3B). The
MBP-U94B K395A mutant displayed a much lower bind-
ing affinity to ssDNA with the CCCTAA motif compared
to MBP-U94B and lost all binding to dsDNA (data not
shown). Similar results were obtained with MBP-U94A
(data not shown). MBP-U94B binding to ssDNA was
highly impaired when the number of CCCTAA repeats was
reduced from 7 (Figure 3C middle panel) to 1 (Figure 3C
top panel). Subsequent experiments indicated that a mini-
Figure 2. HHV-6 U94 binds double-stranded telomeric
(TTAGGG/CCCTAA) probe. Proteins (MBP, MBP-Rep68, MBP-
U94A, MBP-U94B and MBP-U94 K395A) were incubated with 32P
5-end labeled probe for 30 min at 37◦C in the absence or in the presence
of identical or random competitor DNA. Loading dye was added to the
samples and these were separated by electrophoresis on a non-denaturing
gel. After migration the gel was dried and exposed to imaging plates.
Results are representative of two independent experiments.
mum of three CCCTAA motifs was needed to obtain the
maximal MBP-U94B binding (data not shown). Finally, we
could confirm that MBP-U94B also binds human dsDNA
telomeric sequences (Figure 3C bottom panel).
Our results demonstrate that HHV-6A andHHV-6BU94
proteins efficiently bind ssDNA molecules with a greater
affinity for the CCCTAA ssDNA strand of the telomeric
repeats. Lastly, our data show for the first time that HHV-
6A/B U94 proteins are able to bind dsDNA of viral and
human telomeres.
U94 proteins possess ATPase activity
We next determined the HHV-6A/B MBP-U94 ATP and
ADP hydrolyzing activities by HPLC. This first series of
experiments were conducted in the presence of ssDNA
(TAACCC)7. MBP had marginal ATP hydrolysis activity
(Figure 4A). As described previously, ATP and ADP hy-
drolysis by MBP-Rep68 was very efficient and was rapidly
detected (Figure 4B). In fact, the MBP-Rep68 enzyme is
very active and at T = 0, which reflects the interval of
time between the addition of MBP-Rep68 and the time re-
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Figure 3. Analyses of U94 binding to DNA using SPR. Bio-sensor chips coated with various DNA oligonucleotides (Supplementary Table 1) were used
to monitor the binding of MBP-U94 to the different DNAs. (A) Dose-response binding of MBP (negative control) and MBP-Rep68 (positive control)
to various DNA substrates. (B) Dose-response binding of MBP-U94B to various DNA substrates. (C) Dose-response binding of MBP-U94B to a single
CCCTAA motif (top), to 7 CCCTAA motifs (middle) and to human dsDNA telomeric motifs (bottom). Results are representative of three independent
experiments.
quired to stop the reaction (estimated at a few seconds), par-
tial hydrolysis of ATP into ADP is observed. MBP-U94A
(Figure 4C) and MBP-U94B (Figure 4D) were also able to
hydrolyze ATP. Next, we studied whether the presence of
DNA was required for the ATPase activity of MBP-U94.
ATP hydrolysis by MBP-Rep68, MBP-U94A and MBP-
U94B occurred as efficiently in the absence of DNA (data
not shown). These results indicate that the MBP-U94 pro-
teins possess ATPase activity measured by the hydrolyzing
ATP into ADP, which is independent of the presence of a
DNA substrate.
U94 proteins display helicase and exonuclease activities
Unwinding of dsDNA is an energy consuming activity car-
ried out by proteins referred to as helicases. As MBP-
U94 proteins can efficiently generate energy through ATP
hydrolysis, we set to determine if these proteins display
helicase activity. In the first experiment, we investigated
whether MBP-U94 could unwind a partial DNA duplex.
A 20 nt 5′-end labeled probe was hybridized to the 3′ of a 68
nt oligonucleotide, containing eight copies of the CCCTAA
telomeric motif at its 5′ end. Recombinant proteins were in-
cubated with the partial dsDNA duplex for 1 h followed by
electrophoresis on a non-denaturing gel. Both MBP-U94A
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Figure 4. Characterization ofHHV-6U94ATPase activity. Results of ATP,ADP andAMPhydrolysis byMBP (negative control) (A),MBP-Rep68 (positive
control) (B), MBP-U94A (C) andMBP-U94B (D). Results are mean± SD of triplicate percentages of ATP, ADP and AMP relative to the zero time point.
Results are representative of three independent experiments.
and MBP-U94B were able to unwind the labeled probe in a
U94 protein concentration-dependent manner, while MBP
alone did not possess any helicase activity (Figure 5A).
Intriguingly, the released ssDNA labeled probe migrated
faster in the presence of U94, suggesting that the protein
possesses an exonuclease activity. To analyze this in greater
details, the last phosphodiester bond at the 3′ or 5′ end of
the labeled probe was replaced with a PS, making the probe
much more resistant to hydrolysis by exonucleases. The ex-
onuclease resistant probe also protected the substrate from
the helicase activity of MBP-U94 (Figure 5A-B-C, middle
panel), suggesting that in the presence of a 3′ recessed end,
the exonuclease activity of MBP-U94 at a blunt end is lim-
ited. When the PS bond was moved to the probe 5′ end,
both MBP-U94A and MBP-U94B were able to dissociate
the DNA duplex (Figure 5A–C right panel) and the labeled
probe was processed by the U94 exonuclease activity result-
ing in a faster migration compared to the control labeled ss-
DNA. The observation that the 3′ phosphorothioate bond
prevented strands dissociation suggests that MBP-U94 has
weak helicase activity and must rely on its 3′ to 5′ exonucle-
ase activity to reduce the probe length to ∼8–10 nt before it
can be efficiently dissociated from the other strand.
We next determined the influence of probe location on
MBP-U94 helicase/exonuclease activity. To do so, we gen-
erated partial DNA duplexes where the labeled probe hy-
bridized either in the center (Figure 5B) or at the 5′ end
on the 68 nt oligonucleotide (Figure 5C). BothMBP-U94A
and MBP-U94B proteins were capable of separating the
DNA duplex regardless of the location at which the probe
was hybridized, suggesting that MBP-U94 is active against
blunt and 3′ recessive ends but not against 3′ protruding
ends. Every time the helicase activity was observed, the ss-
DNA probe migrated faster indicative of the MBP-U94
exonuclease activity. As presented above, the introduction
of a PS bond at the 3′ end of the probe eliminated the
helicase/exonuclease activity while the introduction of a PS
bond at the 5′ end had no effect, indicating that the exonu-
clease activity occurs in a 3′ to 5′ direction.
We next examined the ATP and divalent ion require-
ments for the MBP-U94 helicase activity, as helicases typ-
ically derive energy to unwind DNA duplex through ATP
(or other nucleotide) hydrolysis. The DNA duplex substrate
was efficiently separated by MBP-U94A in the absence or
in the presence of ATP (Figure 6A), indicating that both
helicase and exonuclease activities are ATP-independent.
Adding apyrase, an agent that depletes ATP, to the MBP-
U94 reaction had no effect on helicase and exonuclease ac-
tivities, ruling out the possibility that ATP co-eluted with
MBP-U94 during purification (not shown). Next, the im-
portance of divalent cations for MBP-U94 activity (in the
absence of ATP) was analyzed. In the absence of MgCl2,
MBP-U94A has no effect on single-stranded (*NS and * C-
Rich) and double-stranded probes (C-Rich/*NS and *C-
Rich/NS) (Figure 6B). Addition of MgCl2 restored MBP-
U94 activity as witnessed by the complete stripping of the
NS probe from its C-Rich counterpart. Similar results were
obtained when the C-Rich strand was end-labeled. When
CaCl2 or ZnCl2 was used in replacement of MgCl2 no ac-
tivity was recorded. Addition of ZnCl2 to MgCl2 also in-
hibited exonuclease/helicase activities of MBP-U94 (data
not shown). Similar results were obtained with MBP-U94B
(data not shown).
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Figure 5. Characterization of HHV-6 U94 helicase/exonuclease activity. MBP and MPB-U94 proteins were incubated with a partial dsDNA duplexes
containing either a 3′ recessed end (A), 5′ and 3′ recessed ends (B) or a 5′ recessed end (C). Asterisk (*) denotes the labeled strand. Proteins were also
incubated with duplexes in which the last (middle panel) or first (right panel) phosphodiester bond was replaced with a phosphorotioate bond ($). After
incubation, samples were analyzed by non-denaturing gel electrophoresis. Gels were dried and exposed to film.Results are representative of two independent
experiments.
We next determined the kinetics of the exonuclease activ-
ity and strands dissociation byMBP-U94A. Partial dsDNA
(Figure 7A) and complete dsDNA templates were analyzed
(Figure 7C). The DNA duplexes were incubated with MBP
or MBP-U94A for various time periods ranging from 5 to
60 min. Strand displacement and exonuclease activity was
rapidly detected with the MBP-U94 proteins, resulting in a
shortening of the probe to 8–10 nt in length over time, while
the MBP control protein did not display any activity after
60 min (Figure 7A). These results indicate that the dsDNA
is attacked from its 3′ end and gradually digested by theU94
exonuclease activity. Once the DNA strand reaches 8–10 nt
in length the two strands separate from each other, possi-
bly through helicase activity of the enzyme. To determine if
MBP-U94A is active on 3′ protruding ends, we generated
a DNA substrate similar to that of Figure 7A except that
the bottom strand was protected with a phosphorothioate
bond at its 3′ end and that the top strand containing a 3′
protruding end was labeled at its 5′ extremity. This DNA
substrate was not attacked by MBP-U94A or MBP-U94B
(Figure 7B), demonstrating that these enzymes are not ac-
tive on 3′ protruding ends. When a blunt dsDNA substrate
was used, we observed various size intermediates including
some full-length probes that remain intact over the late ki-
netic time points (Figure 7C). These results are compatible
with dsDNA being attacked from both sides by U94.
Importance of E27 for U94 exonuclease activity
U94 residues important for the 3′ to 5′ exonuclease activ-
ity could not be deduced from the alignment with Rep68
as this protein lacks such enzymatic activity. While search-
ing for such enzymes we found that the Werner (WRN)
exonuclease/helicase displayed some activities similar to
U94. The N-terminal portion ofWRN and amino acid E84
have been shown to be essential for the exonuclease activity
of WRN (43). After analysis of U94 amino acid sequence,
we identified the amino acid E27 as a potential active site for
the exonuclease activity and mutated it to alanine to gener-
 at Freie U







6092 Nucleic Acids Research, 2015, Vol. 43, No. 12
Figure 6. Characterization of ATP and divalent cations requirements for HHV-6 U94 helicase/exonuclease activity. (A) MBP-U94A was incubated with a
partial dsDNA duplex (C-Rich/NS, Supplementary Table 1) in the absence or in the presence of 10 mM ATP. The asterisk (*) denotes the 5′ end-labeled
strand. After incubation, samples were analyzed by non-denaturing gel electrophoresis. Gels were dried and exposed to film. (B) Proteins were incubated
with partial dsDNA duplexes (C-Rich/NS) in the absence or in the presence of MgCl2, CaCl2 or ZnCl2. The asterisk denotes the 5′ end-labeled strand.
After incubation, samples were analyzed by non-denaturing gel electrophoresis. Gels were dried and exposed to film. Results are representative of three
independent experiments.
ate MBP-U94A E27A. The exonuclease activity of MBP-
U94A and MBP-U94A E27A was tested on various DNA
substrates. Since MBP-U94 preferentially binds telomeric
motifs over unspecific DNA (Figure 3), we generated par-
tial dsDNA substrates with telomeric motifs or random se-
quences. Both dsDNA substrates containing the telomeric
motifs were efficiently processed byMBP-U94Awith no in-
tact probe remaining (Figure 8). Unlike the telomericmotifs
that were completely processed, only a portion of the ran-
dom dsDNA was digested/separated suggesting a higher
processivity rate of U94 on telomeric dsDNA. The MBP-
U94A E27A mutant was unable to process such substrates.
We next studied the effects of MBP-U94A on a 39 bp ds-
DNA duplex containing two 3′ recessive ends. This DNA
structure was simultaneously attacked byMBP-U94A from
both 3′ ends yielding two major products of ∼50 and 40 nt.
When the 3′ end of the upper strand was protected with a
phosphorothioate bond, the non-protected strand was di-
gested all theway down to the end of the upper strand, yield-
ing a 25 nt product. Again, the MBP-U94A E27A mutant
was very ineffective at processing such substrate.
U94 prefers to attack 3′ recessed over blunt ends
From the results presented above, MBP-U94 is able to exert
its 3′ to 5′ exonuclease activity against blunt and 3′ recessive
ends but not over 3′ protruding ends. To determine which
type of DNA ends and expand on the types of substrate
U94 can process, we generated two bubble DNA structures
that differed only in their termini to determine whether U94
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Figure 7. Characterization of HHV-6 U94 exonuclease activity. (A) Proteins were incubated for various periods of time (5–60 min) with a partial dsDNA
duplex with the shorter strand being labeled at its 5′ end, identified by the asterisk (*). After incubation, loading buffer was added and samples boiled for
5 min at 95◦C and immediately chilled on ice. Samples were separated by denaturing gel electrophoresis. Gels were dried and exposed to film. (B) Proteins
were incubated with a partial dsDNA duplex in which the longer strand was 5′ end-labeled (*) and the short strand contained a phosphorotioate bond ($)
at its 3′ end before the last nucleotide. After a 30-min incubation, samples were separated by denaturing gel electrophoresis. Gels were dried and exposed
to film. (C) Same as in (A) except that the dsDNA duplex was blunt at both ends. Results are representative of two independent experiments.
prefers blunt or 3′ recessive ends. Either strand were 5′ end-
labeled and the DNA was subjected to U94 exonuclease
assay. The bubble DNA with two blunt ends was attacked
equally on both sides by MBP-U94 (Figure 9A and B). By
comparison, when a bubble with a blunt and a 3′ recessive
end was used, exonuclease activity was only observed from
the 3′ recessive end (Figure 9A and B).
D-loop destabilization by U94
Telomeres have a 3′ G-rich overhang that allows the forma-
tion of a T-loop by invasion of the double-stranded hex-
amer repeats. As the G-rich strand displaces one strand,
a displacement loop (D) is created (48) (Figure 10A). The
T-loop formation confers some protection from exonucle-
ases and DNA damage responses. To determine if U94 is
able to resolve this protective structure allowing recombina-
tion of the host telomeres with the viral TRS (reviewed in
(8,9)), we determined whether U94 could attack the D-loop
structure and compromise its integrity.We constructed aD-
loop consisting of a bubble with two 33 bp duplex arms and
a 33 bp-melted region in which an invading strand (INV)
that mimics the 3′ telomeric tail (Figure 10B), as described
(43). Analysis by native gel indicated that a D-loop with a
5′-end labeled INV or bottom strand (BB) yielded a single
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Figure 8. Characterization of HHV-6 U94 helicase/exonuclease activity.
Proteins were incubated with various DNA substrates for 30 min at 37◦C.
The asterisk denotes the 5′ end-labeled strand and the $ symbol denotes
phosphorotioate bonds. After incubation samples were either separated by
denaturing. Gels were dried and exposed to film. Results are representative
of two independent experiments.
structure (Figure 10C). Restriction analysis confirmed the
proper alignment (Figure 10D). We incubated MBP and
MBP-U94 with the D-loop and analyzed the products on
native (Figure 10E) and denaturing gels (Figure 10F). At
the lowest doses used, the substrate was not sufficiently pro-
cessed to release the INV strand. However, at the highest
dose of MBP-U94A, we could detect bands migrating be-
low the full-length INV strand (Figure 10E and F). Thus,
the MBP-U94 exonuclease initiated digestion at the INV 3′
end and when sufficient digestion had occurred, the INV
strand was released from the complex. These results suggest
that the U94 helicase and exonuclease cooperate to resolve
the telomeric D-loop, favoring recombination events.
DISCUSSION
HHV-6A and HHV-6B have developed a mechanism that
allows maintenance of the virus genome in infected cells by
integrating their genetic material into the telomeres of host
chromosomes. Based on estimates from several indepen-
dent studies, ∼0.5–1% of world population harbor HHV-
6 in every single cell of their body (iciHHV-6) (reviewed in
(8–10,23)). This suggests that HHV-6 was able to infect a
sperm cell or an ovum and integrate its genome into ga-
metes at some point in time. Kaspersen et al. recently dis-
covered that HHV-6A/B can be detected in 13% of sperm
samples from healthy individuals, indicating that infected
sperm cells could give rise to iciHHV-6 (49). Furthermore,
HHV-6A/B appear to bind to the acrosome suggesting that
it can be transported to the uterus and eventually to the
ovum via sperm cells (49). Once integrated, every cell of the
developing fetus will contain a copy of HHV-6A/B DNA.
The 0.5–1% prevalence of iciHHV-6 therefore only repre-
sents the integration events that occur in gametes. Integra-
tion into somatic cells following primary infection is likely
more frequent and would represent a mechanism allowing
HHV-6A/B to establish latency. However, since these la-
tently infected cells are few and hard to isolate from infected
individuals, they are not detected using conventional tech-
niques (9).
The integration mechanism of HHV-6A/B remains
poorly understood. Another herpesvirus capable of inte-
gration is MDV, an oncogenic alphaherpesvirus that causes
deadly lymphoma in chickens. The precise MDV integra-
tion mechanisms are unknown but it is surmised that the
MDV gene encoding for an RNA telomerase subunit that
shares 88% sequence identity with the chicken telomerase
RNA gene plays a role in MDV genome integration by aid-
ing in the generation of telomeric elongations at the ends
of the viral genome as a prerequisite for integration (30,50).
The TRS encoded by MDV have been shown to facilitate
integration of the virus into host telomeres, a process that
is crucial for efficient pathogenesis and tumor formation.
Although HHV-6A/B also possess TRS at their genome
termini, it remains unknown if these sequences are impor-
tant for integration. A unique protein that has been pro-
posed to facilitate HHV-6A/B integration is the U94 gene
product, U94. U94 shares a sequence homology with the
AAV Rep68, a protein playing an essential role in AAV in-
tegration into human chromosomes (33). To mediate inte-
gration, Rep68 requires at least three basic activities: DNA-
binding, endonuclease and helicase-ATPase activities. The
amino acids or domains essential for these activities were
previously defined (44–46) and have been identified in U94
based on the sequence homology (Figure 2). In the present
work, we have characterized the biochemical properties of
HHV-6A/BU94. Our results indicate the following: (i) U94
is a DNA-binding proteins.We could demonstrate that U94
is capable of binding ssDNA and dsDNA. Gel-shift exper-
iments indicate that U94 binding to DNA can be efficiently
competed with random DNA, suggesting that U94 binds
nucleic acids irrespective of its DNA composition. To de-
termine the affinity of U94 for different DNAmolecules we
performed SPR analyses. Using SPR, we could determine
that HHV-6A/B U94 proteins have greater affinity for cer-
tain DNA molecules such as ssDNA molecules harboring
CCCTAA telomere motifs. Furthermore, our results sug-
gest that HHV-6A/B U94 can also efficiently bind dsDNA
carrying human TRS motifs as well as the TRS sequences
present at the HHV-6A/B genome termini. Binding to the
ssDNA equivalent of the ssRNA TERC revealed some but
minimal binding by U94 suggesting either that a minimum
length is required or that more than one CCCTAA repeat
is required for proper binding. Subsequent experiments in-
dicated that three CCCTAA motifs were needed for maxi-
mal binding; (ii) HHV-6A/B U94 can hydrolyze ATP into
ADP and to a lesser extent ADP into AMP. U94 ATPase
activity is independent of the presence of DNA; (iii) HHV-
6A/B U94 proteins display strong 3′ to 5′ exonuclease ac-
tivity with 3′ recessive ends being the preferred substrates
over blunt ends. No exonuclease activity on 3′ protruding
or 5′ ends was observed. U94 exonuclease activity requires
Mg++ and is inhibited by Ca++ or Zn++ ions; (iv) U94’s have
weak ATP-independent helicase activity. (v) No endonucle-
ase activity could be monitored (not shown); (vi) U94’s can
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Figure 9. U94 prefers 3′ recessed ends over 3′ blunt ends. Strands of bubble DNA structure containing either blunt extremities (left portion of figure) or a 5′
protruding end and a blunt end (right portion of figure) were individually labeled and annealed with their non-labeled complimentary strands. The dsDNA
duplexes were incubated with recombinant proteins for 30 min at 37◦C in reaction buffer. Samples were separated by non-denaturing (A) or denaturing (B)
gel electrophoresis. Gels were dried and exposed to film. For each lane, the labeled strand is indicated by the red or black line. Results are representative of
two independent experiments.
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Figure 10. Telomeric D-loop destabilization by the HHV-6 U94 proteins. (A) Schematic structure of chromosome ends with T- and D-loop structures. (B)
Structure and sequences of the oligonucleotides used to construct the synthetic telomeric D-loop. The 3′ ends of BB and BT oligos are protected with three
phosphorotioate bonds. (C) Analysis of D-loop assembly by non-denaturing gel electrophoresis. The asterisk denotes the labeled strand. (D) Analysis of
D-loop assembly (INV oligo is 5′ end-labeled) by HpaI and FokI restriction endonucleases. After digestion of the D-loop, the samples were boiled and
analyzed by denaturing gel electrophoresis. (E and F) Assembled telomeric D-loop was incubated with proteins for 1 or 2 h after which the samples were
separated by non-denaturing (E) or denaturing (F) gel electrophoresis. Gels were dried and exposed to film. Results are representative of two independent
experiments.
efficiently attack telomeric D-loop structure and compro-
mise its integrity.
U94 enzymatic activities are compatible with a possible
role for these proteins during HHV-6A/B integration into
host telomeres. We surmise that expression of U94 very
early during infection (51,52) would compromise the in-
tegrity of the chromosomal ends by attacking the D-loop
structure generating a partial single stranded DNA strand
with the CCCTAA motif. Simultaneously, it can attack the
3′ ends of the linear viral genome generating 5′ protrud-
ing ends complimentary to the CCCTAA motifs. Anneal-
ing of the DNA molecules would result in the loss of the
pac2 sequence of the DRR, as previously reported (53,54).
The pac1 sequence from the other end of the viral genome is
also missing and proposed to be lost through erosion dur-
ing chromosomal replication (54). Telomeric viral repeats
would then serve as template for telomerase and chromo-
some elongation (54). Homologous recombination was also
proposed as a possible mechanism explaining HHV-6A/B
integration (8,9). Further studies are needed, including the
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generation of a HHV-6 U94 deletion mutant to determine
the relative contribution of this protein during the integra-
tion process.
The integrationmechanisms ofHHV-6A/B that allow in-
sertion of the viral genome into telomeres of germ and so-
matic cells remain poorly understood and should be fur-
ther addressed in the future. An equally important aspect
of iciHHV-6 is whether these viruses can efficiently excise
themselves from host DNA, resulting in the production of
new infectious particles. Although several reports have de-
scribed disease associations in individuals with iciHHV-6,
these individuals appeared otherwise healthy in most cases.
In a recent review cases of iciHHV-6 were tabulated and the
prevalence of iciHHV-6 was 2.3× greater in diseased indi-
viduals relative to controls (10). This suggests that our im-
mune system is able to control sporadic reactivation events
and when our immunity diminishes, such as in transplant
patients, HHV-6 reactivation occurs with possible seque-
lae (55). Endo et al. recently reported convincing in vivo
evidence that under profound immunocompromised con-
ditions (X-SCID), iciHHV-6A can excise itself from inte-
gration and cause disease in humans (56). These results
corroborated previous findings that suggested reactivation
and transplacental transmission of reactivated iciHHV-6 in
pregnant women (57). Such results should prompt trans-
plant clinicians to investigate the iciHHV-6 status of their
patients as well as that of the organs to be transplanted.
In summary, we provided a detailed characterization of
the biological and enzymatic activities of HHV-6A/B U94
proteins. These activities of U94 are compatible with a role
for U94 in HHV-6A/B integration into the telomeres of
host chromosomes and could also contribute to viral exci-
sion, which should be determined in future studies.
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